Syzygium cumini inhibits growth and induces apoptosis in cervical cancer cell lines: a primary study by Barh, D & Viswanathan, G
Syzygium cumini inhibits growth and induces apoptosis in cervical 
cancer cell lines: a primary study 
D Barh and G Viswanathan 
Cancer Research Group, IHMA, Tamil Nadu 613006, India 
Abstract 
Cervical cancer is common among women in the Indian subcontinent and the incidences and death rates are gradually increasing over 
the years. Several dietary phytochemicals have been reported to have growth inhibitory and apoptotic effect on HeLa and other cervical 
cell lines. In this study, using Hoechst 33342 staining, MTT, Annexin V-FLUOS/PI and TUNEL assays we demonstrated that Syzygium 
cumini extract inhibits the growth and induces apoptosis in HeLa and SiHa cervical cancer cell lines in a dose- and time-dependent 
manner. The phytochemical, its mode of action and safety issues are yet to be determined. 
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Introduction 
Cervical cancer is the second most common cancer in women 
worldwide [1] with about a half-million new cases diagnosed 
each year [2]. According to the Indian National Cancer Registry 
Programme of the ICMR (1997), cervical cancer is the most 
common cancer in Indian women, followed by breast, 
oesophagus, ovary and stomach (Table 1) and the incidence is 
increasing, with an estimated rate of 100,000 new cases per 
year [3]. Standard treatment for cervical cancer, that is surgery 
along with taxol chemotherapy, often results in severe 
myelotoxicity and neurotoxicity [4,5]. On the contrary, the 
strategy of targeted apoptosis to neoplastic cells [6] using 
dietary phytochemicals having immunostimulative, antioxidant, 
anti-neoplastic, apoptotic and other physiological benefits are 
showing promising results in in vitro studies for several 
cancers. 
Apoptotic and growth inhibitory effects of curcumin [7–10], aloe 
emodin [11], resveratrol [12–18], retinoic acid [19–22], lycopene 
[23,24] and the tea polyphenol EGCG [25–28] in HeLa and 
other cervical cancer cell lines is well documented. 
In this study, we evaluated the potential growth inhibitory and 
apoptotic effects of Syzygium cumini extract on two cervical 
cancer cell lines (HeLa and SiHa). 
 
Materials and methods 
Syzygium cumini extract  
Crude extracts were isolated from wild-type partially ripe fruit 
skin along with the outermost layer of the berry, and then serial 
dilutions of the extract from 100% to 10% were made using PBS 
for MTT assays. Methanol extracts were prepared for other 
experiments by blending 5 g of skin with 50 ml of methanol at 
4°C. After incubation at 37°C for 15 minutes, the extract was 
centrifuged at 3000 rpm for 10 minutes at 4°C. The supernatant 
was filtered, and the filtrate was vacuum dried and stored at 
4°C. For use the dried extract was dissolved in DMSO and 
diluted with culture medium to a final concentration of 80% (v/v). 
Cell culture  
Human cervical carcinoma cell lines HeLa (HPV-18 positive) 
and SiHa (HPV-16 positive) were cultured in DMEM medium 
(supplemented with 10% FBS, 2 mM glutamine, 100 IU/ml 
penicillin, and 100 μg/ml streptomycin) in 96-well plates at 37°C 
with 5% CO2 and air humidity 95%. Exponentially, growing cells 
were used for experiments. 
A haemocytometer was used for cell counting using the formula: 
Average count/4 × 104 × 10 (dilution factor) = 1.05 × 106 
cells/ml 
Total number of cells = 1.05 × 106 cells/ml × 5ml = 5.25 × 107 
cells 
MTT assay  
The cytotoxic effect of Syzygium cumini crude extract on HeLa 
and SiHa cells was initially determined by MTT assay. In a 96-
well plate, 0.25 ml cultures were added to 0.1 ml medium and 
incubated for two hours. Fifty µl of 100% or 10% extract were 
added to specific test wells; 50 µl PBS was used as a control. 
After 24 hours of culture 100 µl of MTT solution (5.0 mg/ml) was 
added to each well and left for 90 minutes. Culture were then 
washed with 0.1 ml of 10% SDS in a low-speed shaker for 3 
hours and then centrifuged at 100 rpm for 5 minutes. The 
absorbance of 0.9 ml of cell supernatant was read at 570 nm 
against a blank (medium alone). The growth inhibition was 
measured using the following formula: 
Percentage inhibition = [A570(control) - A570 (sample)/ 
A570(control)] × 100. 
The average growth inhibition percentages of triplicates are 
represented in Figure 1. 
Morphological features of apoptosis were evaluated with 
Hoechst 33342 staining, TUNEL (terminal deoxynucleotidyl 
transferase (TdT)-catalysed dUTP-nick end labelling), and 
Annexin V-FLUOS/PI (Propidium Imidone) binding assays using 
phase contrast and fluorescence microscopy. 
Hoechst 33342 staining  
HeLa and SiHa cells seeded in chamber slides overnight were 
treated with 80% (v/v) Syzygium cumini extract. After 24, 36 
and 48 hours of treatment, the medium was removed and the 
cells were washed twice with PBS. Cells were then fixed in 3% 
paraformaldehyde for 30 minutes, washed and stained with 
Hoechst 33342 (10 µg/ml) (Sigma) at 37°C for 30 minutes in the 
dark. After three washes with PBS, mounted slides were viewed 
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Table 1: Leading cancers in population-based cancer registries under the National Cancer Registry Program of ICMR (1997) for women. Figures 
in parenthesis are crude incidence rates per 100,000 
 
 
 
Figure 1: Effect of different concentrations of Syzygium cumini crude extract on growth inhibition of HeLa and SiHa cells, as determined 
by MTT assay.
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Figure 2: Effect of different exposure duration of Syzygium cumini methanolic extract on growth inhibition of HeLa and SiHa cells as 
determined by Hoechst 33342 staining. 
 
Figure 3: Effect of Syzygium cumini methanolic extract on growth inhibition of cervical cancer cell lines. (A) Hoechst 33342 staining for SiHa 
cells at 36 hours; (B) Annexin-V binding assay for HeLa cells at 48 hours; (C) TUNEL assay for SiHa cells at 48 hours.
under a fluorescence microscope at 450–490 nm. The 
percentage of apoptotic cells was determined by cell counting, 
taking the mean count of five microscopic fields (Figure 3A). 
Annexin V-FLUOS/PI assay  
Annexin V-FLUOS/PI Staining Kit (Roche diagnostic) was used 
to determine membrane morphology of treated cells according 
to the manufacturer’s protocol. Briefly, cells were washed with 
PBS and resuspended in binding buffer (2.5 mM CaCl2, 140 
mM NaCl, 10 mM Hepes-NaOH, pH 7.4) followed by the 
addition of fluorescence conjugated Annexin-V (1 µg/ml) and 5 
µg/ml PI and then a 30 minute incubation in the dark. Cells were 
observed under a fluorescence microscope at 488 nm. 
 
TUNEL assay  
TUNEL assay was performed using an in situ Cell Death 
Detection Kit (Roche diagnostic), following the manufacturer’s 
guidelines. In brief, cells were fixed with 4% paraformaldehyde 
and permeabilized (0.1% sodium citrate and 0.1% Triton X-100) 
after washing. Cells were then rewashed and incubated with the 
TUNEL assay reaction mixture for 1 hour at 37°C and 95% air 
humidity. Samples were then analysed under a fluorescence 
microscope at 488 nm. 
Results 
A prominent growth inhibitory effect of Syzygium cumini 
extract on these two cervical cell lines was observed. Different
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dilutions of the extract exhibited growth inhibition in a dose-
dependent manner in both cell lines tested with the MTT assay. 
While the 40% concentration of the extract exhibited 14.4% 
(HeLa) and 11.8% (SiHa) growth inhibition, the 80% 
concentrated extract showed 30.3% and 23.2% growth 
inhibition, respectively, in HeLa and SiHa cell lines. The 100% 
concentration did not show any significant effect over the 80% 
concentration. These results also indicate that the extract is 
more effective on HeLa than on SiHa cells (Figure 1). 
Hoechst 33342 staining indicated condensed chromatin, the 
characteristic pattern of apoptosis, for both the cell lines under 
experiment. The apoptotic indices for these cell lines were 
calculated as mentioned earlier. It has been observed that a 
gradual increase of apoptotic index followed according to the 
treatment duration. Apoptotic cell counts were carried out at 24 
hours (HeLa: 13.1%, SiHa: 12.3%), at 36 hours (HeLa: 17.2%, 
SiHa: 14.6%) and at 48 hours (HeLa: 20.5%, SiHa: 16.1%) 
(Figure 2). It has also been noticed that the methanolic extract 
was less effective as compared to the crude extract at the same 
concentration and the same exposure time. The result for SiHa 
is shown in (Figure 3A). 
To distinguish the nuclear and membrane changes of the cells 
during apoptosis and also to investigate the necrotic cell death 
simultaneously, dual staining of cells with Annexin-V and PI was 
carried out with Annexin-V FLUOS/ PI staining. No PI staining 
was observed after 24 hours treatment, ruling out the possibility 
of necrosis, but fluorescence due to Annexin-V binding to 
phosphatidylserine on the outer cell membrane of the apoptotic 
cells was observed. Figure 3B represents the Annexin-V binding 
assay for HeLa cells at 48 hours. 
The TUNEL assay was performed to detect the DNA strand 
breaks associated with apoptosis. The typical DNA strand 
breaks were detected in apoptotic cells after 24 hours treatment 
as strong fluorescence; these were absent in controls. Figure 
3C) represents the TUNEL assay micrograph for SiHa cells at 
48 hours.  
 
Discussion 
Cervical cancer is the second cause of death from cancer in 
women worldwide, and the pathogenesis is well identified [29–
31]. The treatment options generally followed are mainly 
surgery with or without adjuvant radiotherapy and 
chemotherapy [32–34], which often results in severe side 
effects. 
Medicinal plants play a major role in folk medicine in several 
developing countries. The dietary bioactive phytochemicals, 
namely curcumin, resveratrol, emodin, retinoic acid, lycopene, 
EGCG, and indole-3-carbinol, are not only anti-cancerous, anti-
proliferetive and apoptotic but also have antioxidant, anti-
diabetic, anti-mutagenic and various other physiological benefits 
and so represent a potential alternative to conventional 
chemotherapy and radiotherapy for cervical cancer. The 
screening of medicinal plants for potential anti-cancer properties 
has increased greatly over the years. 
Syzygium cumini of the Myrtaceae family contains bergenin 
(an isocoumarin) [35], myricetin (a flavonol) and several 
polyphenols [36,37], tannins, http://www.herbs2000.com/h_ 
menu/tannins.htm alkaloids (Jambosine), triterpenoids and 
volatile oils. Various parts of the plant are used for treatment of 
a variety of human abnormalities. The seed is able to lower 
blood glucose rapidly and so is effective in treating diabetes 
[38,39] and hyperinsulinemia [40]. Seed extracts are rich in 
phenols and show high-antioxidant activity [41]. It inhibits gastric 
ulceration [42], protects from gamma radiation [43], reduces the 
damage to brain tissue of diabetics [44] and also inhibits alpha-
glucosidase activity [45]. The leaf extract has anti-fungal 
properties [46] and is anti-hyperglycemic and lowers blood 
glucose level in type 2 diabetes [47,48]. It reduces radiation-
induced DNA damage in cultured human lymphocytes [49], can 
dissolve human gallbladder stones in vitro [50], protects from 
carbon tetrachloride-induced hepatotoxicity [51] and inhibits 
goatpox virus replication [52]. Its anti-allergic and anti-
edematogenic effect is brought about by inhibiting histamine, 
serotonin, CCL11, IL-5 and mast cell degranulation [53]. 
Essential oils from the leaf have been reported to have anti-
bacterial activity [54] and the bark has anti-inflammatory [55], 
gastroprotective [56] and anti-diarrhoeal [57] activities. The fruit 
skin has been reported to have antioxidant activity [58] and the 
fruit pulp an anti-hyperglycemic effect [59]. 
This study shows that extract of Syzygium cumini fruit skin 
along with the outermost layer of the berry inhibits growth and 
induces apoptosis in both HeLa and SiHa cervical cancer cell 
lines in a dose- and time-dependent manner. Whereas the 
crude extract exhibited, respectively, 33.7 % and 24.4% growth 
inhibition in HeLa and SiHa cells at its highest concentration 
(100%) in MTT assay, the methanolic extract (80% v/v) showed 
an apoptotic index of 20.5% and 16.1%, respectively, for these 
cell lines as determined by Hoechst 33342 staining. It has also 
been found that the crude extract is more effective in growth 
inhibition and apoptosis than the methanolic extract at its most 
effective concentration (80%). Annexin-V binding and TUNEL 
assays also confirm the apoptotic effect of the extract. 
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Conclusion 
In conclusion, the study confirms a dose- and time-dependent 
growth inhibitory and apoptotic effect of Syzygium cumini 
extract on the cervical cancer cell lines HeLa (HPV-18 positive) 
and SiHa (HPV-16 positive). Syzygium cumini fruit contains 
gallic acid, which has anti-adenoviral, anti-HIV, anti-peroxidant, 
anti-carcinomic, apoptotic and chemopreventive activities and is 
a topoisomerase-I-inhibitor (Dr Duke's Phytochemical and
Ethnobotanical Databases: http://www.ars-grin.gov/duke/). 
Though the results of this study indicate the growth inhibitory 
and apoptotic effect of the extract, the chemical component(s) 
responsible for these phenomena is/are yet to be precisely 
identified. Similarly, the anti-viral effect in respect to HPV-18 
and HPV-16 is yet to be confirmed by further experiments. 
Moreover, further research is needed to identify the mode of 
action, efficacy and safety issues. 
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